サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/04/06 | 3,390 | 3,420 | 3,250 | 3,265 | -155 | -4.5% | 400,700 |
2018/04/05 | 3,395 | 3,445 | 3,345 | 3,420 | +80 | +2.4% | 235,700 |
2018/04/04 | 3,420 | 3,450 | 3,280 | 3,340 | -55 | -1.6% | 256,000 |
2018/04/03 | 3,330 | 3,440 | 3,325 | 3,395 | -40 | -1.2% | 293,700 |
2018/04/02 | 3,565 | 3,655 | 3,435 | 3,435 | -120 | -3.4% | 619,300 |
2018/03/30 | 3,350 | 3,575 | 3,335 | 3,555 | +240 | +7.2% | 561,900 |
2018/03/29 | 3,230 | 3,385 | 3,185 | 3,315 | +100 | +3.1% | 355,700 |
2018/03/28 | 3,200 | 3,280 | 3,165 | 3,215 | +10 | +0.3% | 347,600 |
2018/03/27 | 3,335 | 3,450 | 3,200 | 3,205 | -115 | -3.5% | 681,200 |
2018/03/26 | 3,670 | 3,670 | 3,285 | 3,320 | -365 | -9.9% | 786,500 |
2018/03/23 | 3,555 | 3,715 | 3,535 | 3,685 | -30 | -0.8% | 539,100 |
2018/03/22 | 3,500 | 3,745 | 3,465 | 3,715 | -85 | -2.2% | 855,400 |
2018/03/20 | 3,795 | 3,860 | 3,750 | 3,800 | -70 | -1.8% | 308,900 |
2018/03/19 | 3,955 | 3,965 | 3,790 | 3,870 | -125 | -3.1% | 374,600 |
2018/03/16 | 4,225 | 4,290 | 3,835 | 3,995 | -255 | -6% | 681,700 |
2018/03/15 | 4,410 | 4,455 | 4,190 | 4,250 | -90 | -2.1% | 624,000 |
2018/03/14 | 4,135 | 4,460 | 4,125 | 4,340 | +240 | +5.9% | 1,544,500 |
2018/03/13 | 3,980 | 4,120 | 3,930 | 4,100 | +90 | +2.2% | 422,700 |
2018/03/12 | 3,925 | 4,020 | 3,895 | 4,010 | +125 | +3.2% | 410,500 |
2018/03/09 | 3,970 | 3,980 | 3,825 | 3,885 | +50 | +1.3% | 353,400 |
2018/03/08 | 3,860 | 3,890 | 3,775 | 3,835 | +40 | +1.1% | 234,400 |
2018/03/07 | 3,715 | 3,850 | 3,625 | 3,795 | +110 | +3% | 332,800 |
2018/03/06 | 3,680 | 3,725 | 3,625 | 3,685 | +180 | +5.1% | 328,800 |
2018/03/05 | 3,780 | 3,835 | 3,430 | 3,505 | -300 | -7.9% | 579,600 |
2018/03/02 | 3,785 | 3,850 | 3,750 | 3,805 | -85 | -2.2% | 260,200 |
2018/03/01 | 3,820 | 3,920 | 3,770 | 3,890 | ±0 | ±0% | 382,000 |
2018/02/28 | 3,895 | 3,985 | 3,890 | 3,890 | -40 | -1% | 339,600 |
2018/02/27 | 4,000 | 4,030 | 3,905 | 3,930 | +30 | +0.8% | 374,600 |
2018/02/26 | 3,995 | 4,135 | 3,880 | 3,900 | +170 | +4.6% | 1,201,700 |
2018/02/23 | 3,695 | 3,770 | 3,660 | 3,730 | +80 | +2.2% | 355,400 |
2018/02/22 | 3,700 | 3,760 | 3,570 | 3,650 | -60 | -1.6% | 374,400 |
2018/02/21 | 3,690 | 3,815 | 3,645 | 3,710 | -20 | -0.5% | 567,300 |
2018/02/20 | 3,630 | 3,755 | 3,555 | 3,730 | +120 | +3.3% | 484,100 |
2018/02/19 | 3,470 | 3,650 | 3,440 | 3,610 | +140 | +4% | 445,700 |
2018/02/16 | 3,620 | 3,690 | 3,435 | 3,470 | -125 | -3.5% | 705,400 |
2018/02/15 | 3,305 | 3,680 | 3,300 | 3,595 | +230 | +6.8% | 936,300 |
2018/02/14 | 3,205 | 3,445 | 3,195 | 3,365 | +125 | +3.9% | 629,100 |
2018/02/13 | 3,545 | 3,560 | 3,240 | 3,240 | -235 | -6.8% | 626,000 |
2018/02/09 | 3,040 | 3,485 | 3,015 | 3,475 | +15 | +0.4% | 1,070,100 |
2018/02/08 | 3,600 | 3,670 | 3,415 | 3,460 | ±0 | ±0% | 1,162,000 |
2018/02/07 | 3,800 | 4,085 | 3,425 | 3,460 | +45 | +1.3% | 1,733,000 |
2018/02/06 | 3,830 | 3,930 | 3,410 | 3,415 | -695 | -16.9% | 1,919,600 |
2018/02/05 | 4,015 | 4,150 | 3,955 | 4,110 | -55 | -1.3% | 607,900 |
2018/02/02 | 4,255 | 4,285 | 4,055 | 4,165 | -45 | -1.1% | 417,700 |
2018/02/01 | 4,095 | 4,230 | 4,045 | 4,210 | +185 | +4.6% | 443,100 |
2018/01/31 | 4,130 | 4,270 | 4,025 | 4,025 | -190 | -4.5% | 599,600 |
2018/01/30 | 4,035 | 4,265 | 3,980 | 4,215 | +110 | +2.7% | 904,300 |
2018/01/29 | 4,405 | 4,420 | 4,080 | 4,105 | -290 | -6.6% | 879,000 |
2018/01/26 | 4,495 | 4,565 | 4,365 | 4,395 | -60 | -1.3% | 884,100 |
2018/01/25 | 4,250 | 4,460 | 4,190 | 4,455 | +230 | +5.4% | 803,300 |
1801~
1850
件表示中 / 2535件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 253,700円 | - | - | 0.00% | - | 117.51倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 152,300円 | +5.0% | +1.5% | 0.00% | 13.03倍 | 3.67倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
科研薬 | 388,000円 | -6.4% | -71.8% | 4.90% | 43.22倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 304,500円 | +7.9% | -3.3% | 2.63% | 8.47倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム